FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085143940> ?p ?o ?g. }

• W2085143940 endingPage "1868" @default.
• W2085143940 startingPage "1859" @default.
• W2085143940 abstract "Abstract Purpose: The altered PI3K/mTOR pathway is implicated in lung cancer, but mTOR inhibitors have failed to demonstrate efficacy in advanced lung cancer. We studied the pharmacodynamic effects of everolimus in resectable non–small cell lung cancer (NSCLC) to inform further development of these agents in lung cancer. Experimental Design: We enrolled 33 patients and obtained baseline tumor biopsy and 2[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) imaging followed by everolimus treatment (5 or 10 mg daily, up to 28 days), or without intervening treatment for controls. Target modulation by everolimus was quantified in vivo and ex vivo by comparing metabolic activity on paired PET scans and expression of active phosphorylated forms of mTOR, Akt, S6, eIF4e, p70S6K, 4EBP1, and total Bim protein between pretreatment and posttreatment tissue samples. Results: There were 23 patients on the treatment arm and 10 controls; median age 64 years; 22 tumors (67%) were adenocarcinomas. There was a dose-dependent reduction in metabolic activity (SUVmax: 29.0%, −21%, −24%; P = 0.014), tumor size (10.1%, 5.8%, −11.6%; P = 0.047), and modulation of S6 (−36.1, −13.7, −77.0; P = 0.071) and pS6 (−41.25, −61.57, −47.21; P = 0.063) in patients treated in the control, 5-mg, and 10-mg cohorts, respectively. Targeted DNA sequencing in all patients along with exome and whole transcriptome RNA-seq in an index patient with hypersensitive tumor was employed to further elucidate the mechanism of everolimus activity. Conclusions: This “window-of-opportunity” study demonstrated measurable, dose-dependent, biologic, metabolic, and antitumor activity of everolimus in early-stage NSCLC. Clin Cancer Res; 21(8); 1859–68. ©2015 AACR." @default.
• W2085143940 created "2016-06-24" @default.
• W2085143940 creator A5002430008 @default.
• W2085143940 creator A5008436285 @default.
• W2085143940 creator A5012015166 @default.
• W2085143940 creator A5015060656 @default.
• W2085143940 creator A5022930216 @default.
• W2085143940 creator A5023971012 @default.
• W2085143940 creator A5030308961 @default.
• W2085143940 creator A5031352775 @default.
• W2085143940 creator A5036672833 @default.
• W2085143940 creator A5042210553 @default.
• W2085143940 creator A5043235685 @default.
• W2085143940 creator A5046219279 @default.
• W2085143940 creator A5046360681 @default.
• W2085143940 creator A5046410639 @default.
• W2085143940 creator A5052955777 @default.
• W2085143940 creator A5059710197 @default.
• W2085143940 creator A5059872561 @default.
• W2085143940 creator A5060714112 @default.
• W2085143940 creator A5061713130 @default.
• W2085143940 creator A5064037990 @default.
• W2085143940 creator A5072454821 @default.
• W2085143940 creator A5088178599 @default.
• W2085143940 creator A5088837180 @default.
• W2085143940 creator A5090472587 @default.
• W2085143940 date "2015-04-14" @default.
• W2085143940 modified "2023-10-14" @default.
• W2085143940 title "A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung Cancer" @default.
• W2085143940 cites W1967827870 @default.
• W2085143940 cites W1980497534 @default.
• W2085143940 cites W1982590492 @default.
• W2085143940 cites W1985182434 @default.
• W2085143940 cites W1988303870 @default.
• W2085143940 cites W1992512309 @default.
• W2085143940 cites W1995435221 @default.
• W2085143940 cites W2001999652 @default.
• W2085143940 cites W2013335096 @default.
• W2085143940 cites W2016480900 @default.
• W2085143940 cites W2019697444 @default.
• W2085143940 cites W2033780390 @default.
• W2085143940 cites W2043696829 @default.
• W2085143940 cites W2048351900 @default.
• W2085143940 cites W2050146483 @default.
• W2085143940 cites W2055402151 @default.
• W2085143940 cites W2057223714 @default.
• W2085143940 cites W2073759100 @default.
• W2085143940 cites W2087452619 @default.
• W2085143940 cites W2091134276 @default.
• W2085143940 cites W2093171632 @default.
• W2085143940 cites W2102088611 @default.
• W2085143940 cites W2102148658 @default.
• W2085143940 cites W2115686439 @default.
• W2085143940 cites W2117986690 @default.
• W2085143940 cites W2118677643 @default.
• W2085143940 cites W2126783165 @default.
• W2085143940 cites W2130404083 @default.
• W2085143940 cites W2130488043 @default.
• W2085143940 cites W2132292320 @default.
• W2085143940 cites W2134964552 @default.
• W2085143940 cites W2141744105 @default.
• W2085143940 cites W2142364508 @default.
• W2085143940 cites W2142865455 @default.
• W2085143940 cites W2149218373 @default.
• W2085143940 cites W2152636515 @default.
• W2085143940 cites W2153493705 @default.
• W2085143940 cites W2155263737 @default.
• W2085143940 cites W2156800473 @default.
• W2085143940 cites W2167188058 @default.
• W2085143940 cites W2170932239 @default.
• W2085143940 cites W2170984340 @default.
• W2085143940 cites W2590474296 @default.
• W2085143940 cites W4245276995 @default.
• W2085143940 doi "https://doi.org/10.1158/1078-0432.ccr-14-1998" @default.
• W2085143940 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4401630" @default.
• W2085143940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25673697" @default.
• W2085143940 hasPublicationYear "2015" @default.
• W2085143940 type Work @default.
• W2085143940 sameAs 2085143940 @default.
• W2085143940 citedByCount "19" @default.
• W2085143940 countsByYear W20851439402015 @default.
• W2085143940 countsByYear W20851439402016 @default.
• W2085143940 countsByYear W20851439402017 @default.
• W2085143940 countsByYear W20851439402018 @default.
• W2085143940 countsByYear W20851439402019 @default.
• W2085143940 countsByYear W20851439402020 @default.
• W2085143940 countsByYear W20851439402021 @default.
• W2085143940 crossrefType "journal-article" @default.
• W2085143940 hasAuthorship W2085143940A5002430008 @default.
• W2085143940 hasAuthorship W2085143940A5008436285 @default.
• W2085143940 hasAuthorship W2085143940A5012015166 @default.
• W2085143940 hasAuthorship W2085143940A5015060656 @default.
• W2085143940 hasAuthorship W2085143940A5022930216 @default.
• W2085143940 hasAuthorship W2085143940A5023971012 @default.
• W2085143940 hasAuthorship W2085143940A5030308961 @default.
• W2085143940 hasAuthorship W2085143940A5031352775 @default.
• W2085143940 hasAuthorship W2085143940A5036672833 @default.
• W2085143940 hasAuthorship W2085143940A5042210553 @default.

• next